These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 7293730
1. Duchenne muscular dystrophy. Morphological study of erythrocytes after treatment with L-alpha-lysophosphatidyl-choline in dystrophic patients and in the carrier state. Dellantonio R, Capriotti M, Angeleri F, Curatola G, Mazzanti L, Bertoli E, Lenaz G. Acta Neurol Belg; 1981; 81(4):193-8. PubMed ID: 7293730 [Abstract] [Full Text] [Related]
2. [Erythrocyte membrane in Duchenne muscular dystrophy. I. Sensitivity to lysolecithin in dystrophic patients and their families]. Grilli G, Bravi S, Angeleri F, Colombi A. Boll Soc Ital Biol Sper; 1980 Dec 15; 56(23):2399-402. PubMed ID: 7470282 [Abstract] [Full Text] [Related]
3. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection. Tangorra A, Curatola G, Milani-Comparetti M, Ferretti G. Am J Med Genet; 1989 Apr 15; 32(4):540-4. PubMed ID: 2774000 [Abstract] [Full Text] [Related]
4. Morphological variations of erythrocytes in Duchenne muscular dystrophy and in carrier state. Capriotti M, Dellantonio R, Angeleri F, Curatola G, Mazzanti L, Bertoli E, Lenaz G, Leporoni B. Boll Soc Ital Biol Sper; 1980 Jul 30; 56(14):1459-64. PubMed ID: 7448043 [No Abstract] [Full Text] [Related]
5. Progressive muscular dystrophy type Duchenne. II. Viscosity and resistence to erythrolytic compounds of erythrocyte membranes. Capriotti M, Dellantonio R, Di Bella P, Angeleri F, Bertoli E, Curatola G, Lenaz G. Boll Soc Ital Biol Sper; 1979 Jun 30; 55(11):1028-32. PubMed ID: 549581 [Abstract] [Full Text] [Related]
6. [Morphology and deformability of erythrocytes in muscular dystrophy]. Garceau C, Leblond PF, Lyonnais J, Beaupré A. Nouv Rev Fr Hematol (1978); 1979 Jan 30; 20(4):585-98. PubMed ID: 375191 [Abstract] [Full Text] [Related]
7. [Blood myoglobin in children with progressive muscular dystrophy and in carriers]. Calandi C, Baretti S, Pacciani G, Bagni P, Borsotti M, Tozzi P, Adami Lami C. Quad Sclavo Diagn; 1984 Dec 30; 20(4):391-8. PubMed ID: 6537549 [Abstract] [Full Text] [Related]
8. Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy. Sato B, Nishikida K, Samuels LT, Tyler FH. J Clin Invest; 1978 Feb 30; 61(2):251-9. PubMed ID: 23391 [Abstract] [Full Text] [Related]
9. Susceptibility of erythrocyte membranes to treatment with L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy. Tangorra A, Curatola G, Milani Comparetti M, Ferretti G. Boll Soc Ital Biol Sper; 1988 May 30; 64(5):477-84. PubMed ID: 3179030 [No Abstract] [Full Text] [Related]
11. Plasma lipoproteins in Duchenne muscular dystrophy. Arthur H, de Niese M, Jeffrey PL, Austin L. Biochem Int; 1983 Mar 30; 6(3):307-13. PubMed ID: 6679326 [Abstract] [Full Text] [Related]
15. [Effects of propranolol and ouabain on ATP in erythrocytes from healthy adults and patients with Duchenne muscular dystrophy (author's transl)]. Igisu H. Fukuoka Igaku Zasshi; 1979 Jul 30; 70(7):361-9. PubMed ID: 478426 [No Abstract] [Full Text] [Related]